Product Information
LAMOTRIGINE ER 300 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $1.2133 per EA under NDC 31722024530. Its NADAC has been published 178 times since Feb 8, 2023.
Strength
300 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722024530
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LAMOTRIGINEApproval Type
Generic (ANDA)
FDA Application
ANDA213949On Market Since
12/9/2021
Pharmacological Classes
Price Statistics
The NADAC for LAMOTRIGINE ER 300 MG TABLET has been published 178 times since Feb 8, 2023, and over the history we have for it it has declined 58.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2133 per EA |
|---|---|
| All-time high | $3.3254 (Mar 15, 2023) |
| All-time low | $0.9867 (Nov 20, 2024) |
| 52-week high | $1.4630 |
| 52-week low | $1.2016 |
| Median price | $1.4630 |
| Average price | $1.7464 |
| Largest weekly change | +59.8% (Jun 19, 2024) |
| Weeks tracked | 178 |
| Tracking since | Feb 8, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the lamotrigine extended-release market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of LAMOTRIGINE ER 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE ER 300 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $1.2133 per EA (NDC 31722024530), effective Jul 1, 2026.
How has the price of LAMOTRIGINE ER 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMOTRIGINE ER 300 MG TABLET has declined 58.4%. It has been tracked across 178 weekly CMS publications since Feb 8, 2023.
What are the highest and lowest recorded NADAC prices for LAMOTRIGINE ER 300 MG TABLET?
Since Feb 8, 2023, the NADAC for LAMOTRIGINE ER 300 MG TABLET has ranged from a low of $0.9867 (Nov 20, 2024) to a high of $3.3254 (Mar 15, 2023), with a median of $1.4630 per EA.
Are there cheaper alternatives to LAMOTRIGINE ER 300 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LAMOTRIGINE ER 300 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures LAMOTRIGINE ER 300 MG TABLET?
LAMOTRIGINE ER 300 MG TABLET (NDC 31722024530) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification